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Abstract 
The fields of tissue engineering and regenerative medicine utilize implantable biomaterials and 
engineered tissues to regenerate damaged cells or replace lost tissues. There are distinct 
challenges in all facets of this research, but functional assessments and monitoring of such 
complex environments as muscle tissues present the current strategic priority. Many extant 
methods for addressing these questions result in the destruction or alteration of  tissues or cell 
populations under investigation. Modern advances in non-invasive imaging modalities present 
opportunities to rethink some of the anachronistic methods, however, their standard 
employment may not be optimal when considering advancements in myology. New image 
analysis protocols and/or combinations of established modalities need to be addressed. This 
review focuses on efficacies and limitations of available imaging modalities to the functional 
assessment of implantable myogenic biomaterials and engineered muscle tissues. 
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 Tissue engineering and regenerative medicine are 
rapidly growing fields of research that aim to use a 
multi-disciplinary approach to restore or replace tissues 
that have either been damaged or lost through diseases 
or trauma. Although strategies for restoring function 
and structure typically vary considerably, most 
investigations involve the use of cells, biomaterial 
scaffolds, and various inducible factors, that are either 
first incubated in bioreactors or directly implanted in 
vivo. The complex environments that these components 
and methodologies generate present unique challenges 
– not only in generating functional engineered tissue, 
but in monitoring and assessing outcomes both in vitro 
and in vivo. 
Of the many tissue types under investigation in these 
fields, the creation of new muscle through tissue 
engineering represents a promising alternative to the 
replacement of tissue after either severe damage or 
degeneration from various myopathies.
1-4
 Surgical 
reconstruction in patients with significant muscle tissue 
loss typically utilizes transferred tissue from local 
and/or distant sites, which often results in significant 
local denervation, functional loss, and/or volume 
deficiency.
5,6
 The engineering of lost connective, 
nervous, and muscular tissue on a patient-specific basis 
has been suggested by many to represent the future of 
muscle surgical reconstruction.
7-9
 Likewise, tissue 
engineering approaches have been suggested for 
treating musculoskeletal myopathies such as spinal 
muscular atrophy or Duchenne muscular dystrophy 
(DMD).
10-12
 However, a common challenge remains in 
either approach to muscular regeneration – how best to 
non-invasively assess the viability and function of 
engineered or extant muscle tissue, both in vitro and in 
vivo. 
Functional Assessment in Myology 
As in every focus of tissue engineering, engineered 
muscle tissues should exhibit biomimetic functional 
properties and recapitulate native structure – 
specifically with regards to densely packed and 
uniformly aligned myofibers throughout the tissue 
volume.
1
 As such, methods for assessing cellular 
viability, proliferation, biological integration, and/or 
differentiation are crucial to identify optimal strategies. 
What is herein broadly referred to as the "functional 
assessment" of engineered muscle tissue and/or 
implantable biomaterials depends largely on the 
methodology employed in the particular investigation. 
In the case where large volumes of muscle, nervous, 
and connective tissue must be replaced, regeneration 
may not be possible by the exclusive transplantation of 
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autologous cells – rather, a bioreactor-based approach 
may be prescribed, wherein large-volume tissue 
formation is initiated and controlled prior to 
implantation. In contrast, in considering general 
musculoskeltal degeneration due to a particular 
myopathy, regeneration might be optimally achieved 
through the injection of myoblasts or relevant 
multipotent progenitor cells, both with or without 
biomaterials and/or therapeutic factors, to stimulate the 
release of soluble signals, the formation of 
extracellular matrix (ECM), and/or the incorporation of 
new tissues. In either approach to regeneration, 
functional assessment of engineered cells or large-
volume tissues remains a crucial step in quantitatively 
andnon-destructively characterizing and monitoring the 
dynamic and complex interactions of the host site and 
engineered cells and/or large-volume of muscle 
tissue.
13
 Such assessments are crucial in understanding 
the optimal methods for rational control of muscle 
tissue structure and function via complex, temporally-
dependent interactions between cells, biomolecules, 
and engineered scaffolds. 
Traditional Functional Assessments and the 
Expanding Role of Imaging 
There are many standard analysis methods currently 
available for tissue engineers to be utilized at both the 
individual cell and whole-tissue levels, but all of them 
have their innate limitations (Fig. 1). For example, 
metabolomic assays offer only a temporal snapshot of 
tissue physiological function – an assessment that 
likewise kills the construct in question.
4,14,15
 MTT 
assays can be used as a quick and relatively simple 
assay for cellular metabolic activity (and, indirectly, 
viability) but is limited by the use of the tetrazolium 
dye, as only certain cells can participate in its 
reduction.
16
 Other methods such as fluorescent 
immunohistological staining or tissue biopsy are labor 
intensive, invasive, and destructive; thus, multiple 
timepoints and endpoint studies must be performed and 
temporal correlation inferred. Rendering engineered 
cells unrecoverable is of particular concern in cell 
therapy investigations, where cells and implantable 
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Fig 1. Types of functional assessment metrics for various tissue engineering studies. A) Proliferation of 
cardiomyocytes measured by immunohistochemical staining of phosphohistone H3 
15
. B) Muscle cells viability 
measured in cells stained with CellTracker™ Green and propidium iodide showing dying myocytes.136 C) 
Periphery of implanted engineered muscle showing neonatal rat satellite cells and their myogenic 
predifferentiation via f-actin filamentous formation and integration with extant, CD31-labeled endotheilial 
cells.
137 
D) CT reconstructions of denervated thigh muscle that was electrically stimulated for growth, 
highlighting a possible modality for measuring myogenesis in engineered muscle tissue.
143,144
 E) Changes in 
redox ratios observed in adipogenic differentiation with TPEF along with characteristic, non-autofluorescent 
lipid droplets.
40
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biomaterials are introduced to their hosts and tracked 
over time to assess both viability and cell fate.
13, 17-20
 
To alleviate these concerns, several noninvasive 
imaging techniques have recently been developed to 
obtain information on both cell metabolism and fate in 
engineered tissues.
21-29
 These methods exploit a 
number of intrinsic cellular phenomena, such as 
autoﬂuorescence and tissue glycolysis. While many of 
these methods have shown considerable promise, it is 
important to comprehensively distill their respective 
benefits and limitations, as there exists a clear need for 
the development of an assessment platform that 
operates in real-time, at relevant tissue depths and in 
vivo. 
High resolution imaging methods that can allow for 
noninvasive, real-time assessment of cellular and 
tissue-level function within engineered muscle could 
provide significant aid to the fields of tissue 
engineering and regenerative medicine. These methods 
have readily been identified as a strategic priority in 
other venues of tissue engineering research, and extant 
applicable imaging modalities have been identified; 
however, their employment via standard methods may 
not be optimal when considering advances in myology 
research.
30
 While researchers continue to address many 
of these concerns, there is yet relatively little literature 
offering a comprehensive assessment of modern 
approaches to noninvasive functional imaging of 
engineered muscle and myogenic biomaterials. This 
review presents these modalities to guide and promote 
current discussion on the development and evaluation 
of optimal methods, in particular for myology 
applications. 
Non-Destructive?
Destructive
Functional Assessment
A
C
B
 
 
Fig. 2 Standard destructive methods for the functional analysis of engineered tissue 
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Two-Photon Excited Fluorescence 
As previously mentioned, non-invasive imaging 
techniques that take advantage of the endogenous 
fluorophores of cells have been in development for 
decades.
31-34 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC384221
2/ - R8. Many of these modalities have investigated the 
quantification of cellular and tissue metabolic state 
through fluorescent excitation of both the primary 
electron donor and receptor in cellular respiration: 
nicotinamide adenine dinucleotide (NADH) and flavin 
adenine dinucleotide (FAD), respectively. In its 
reduced form, NADH may be fluorescently excited at 
350 nm (emission maximum at 460 nm), whereas its 
oxidized counterpart, NAD+, is non-fluorescent.
35
 
Likewise, FAD has fluorescent excitation and emission 
maxima of 450 nm and 535 nm, respectively.
36
 During 
high tissue metabolic demand, the ratio of 
mitochondrial NADH to NAD+ decreases, resulting in 
a markedly reduced fluorescent profile which therein 
allows for the single-channel (350 nm) assessment of 
respiration within the mitochondrial matrix space.
37, 38
 
Alternatively, both an 350 nm and 450 nm excitation 
may be employed to obtain an approximation of the 
mitochondrial oxidation-reduction ratio, or the ratio of 
the fluorescent intensity of FAD to that of NADH. 
Two-photon excited fluorescence (TPEF) is a 
promising method for the imaging of mitochondrial 
redox ratios in vivo, since it offers high resolution 
(approx. 400 nm) at relatively large tissue depths 
(approx. 1 mm).
36, 39, 40
 Two-photon excitation occurs 
when a fluorophore interacts with two photons whose 
energies are equal to half of the excitation energy of 
that particular fluorophore. These fluorophores can be 
the same target probed by single-photon 
fluorescence.
41
 Both NADH and FAD can be readily 
excited by two-photon excitation at near infrared 
wavelengths (650-900 nm). Excitation wavelengths 
from 710-780 nm results in NADH excitation, whereas 
oxidized flavoprotein in FAD may be excited from 
700-900 nm, and these wavelength ranges are both 
relatively safe, yet highly penetrative, due to reduced 
scattering and absorption as the excitation volume is 
inherently confined by its non-linear dependence on 
incident beam intensity.
42-44
 As such, many recent 
investigations have employed TPEF of NADH and 
FAD to monitor metabolism of many tissue types, 
including cardiac, corneal, pancreatic, and brain.
42, 44-52
 
TPEF is a promising modality for the functional 
assessment of glycolysis and oxidative phosphorylation 
in engineered tissues due primarily to its non-
destructive use of infrared light, as opposed to UV 
excitation otherwise inherent to single-photon excited 
fluorescence. However, despite TPEF being a 
relatively deeply-penetrating optical method, its 
maximum penetration depth of 1 mm is its greatest 
drawback when considering the assessment of deeper 
tissues. 
Photoacoustic Microscopy 
Photoacoustic Microscopy (PAM) is a hybrid modality 
combining principles of ultrasound detection and what 
is known as the photoacoustic effect. In PAM, pulses 
of near-infrared light are absorbed rapidly by a tissue 
and quickly converted to heat which leads to a transient 
thermoelastic expansion. This expansion propagates as 
an ultrasonic wave and is eventually detected by an 
ultrasound transducer.
53,54
 Structural and functional 
information of various tissue morphologies can be 
readily determined, as photoacoustic absorption varies 
strongly with oxyhemoglobin content. As such, many 
recent studies have successfully resolved both the 
structure and oxygenation levels of complex tissues 
and vasculatures down to the capillary level.
55,56
 PAM 
has been suggested by many for its utility in tissue 
engineering applications. Due to its inherent ability to 
detect functional vasculature, PAM has already been 
used to resolve angiogenesis in tumors: a crucial metric 
in assessing the biological integration of engineered 
tissue.
57-59
 Likewise, neovascularization and cellular 
distribution within implantable biomaterials, such as 
porous polymer foams,
56,60
 mesenchymal stem cell 
seeded hydrogels,
61
 and cell-free hydrogels containing 
the growth factor FGF-2,
62
 have been monitored using 
PAM. Introducing contrast agents such as gold 
 
Table 1. Target pathophysiology of various 
18
F-containing radiopharmaceuticals.
92
 
 
  
 Pathophysiology Target Radiopharmaceutical 
____________________________________________________________________________________________ 
 
 Metabolism 
18
F-fluorodeoxyglucose (
18
F-FDG) 
 Cell Proliferation 9-(4-fluoro-
18
F-3-hydroxymethybutyl 
 Gene Expression guanine (
18
F-FHB G) 
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particles to engineered tissues, biomaterials, or injected 
cells has likewise proven successful for researchers 
investigating blood oxygen saturation levels and stem 
cell trafficking.
63-65
 In general, PAM offers a number 
of benefits over other functional imaging methods, but 
its maximum depth of penetration (approx. 3 mm) and 
its dependency on local laser fluence might make 
longitudinal studies of deeper tissues prohibitively 
difficult to perform. 
Fluorescence-Lifetime Imaging Microscopy 
As previously mentioned, improvements in the field 
of multiphoton microscopy present a great 
opportunity for both high-resolution and long-term 
imaging of engineered tissues and biomaterials. Due 
to both its intrinsic 3D resolution and high depth of 
penetration, multiphoton microscopy allows for the 
investigation of a local environment in femtoliter 
volumes located deep within tissues.
40,66
 
Investigations utilizing multiphoton microscopy take 
advantage of the autofluorescent nature of 
endogenous fluorophores, such as  collagen, elastin, 
porphyrin, ﬂavin, hemoglobin, serotonin, and as 
previously discussed, NADH and FAD.
42,44-52
 
However, using emission wavelengths to 
discriminate between multiple fluorescent species 
within the same focal volume is majorly limited by 
their emission spectra overlap.
42
 
Fluorescence-Lifetime Imaging Microscopy (FLIM) 
is a promising imaging modality that has elicited 
many successes in monitoring the differentiation of 
stem cells.
21,27,67,68
 Additionally, FLIM has been 
shown to have utility in separating NADH and 
NADPH emission spectra, aiding greatly in the 
study of the photochemistry of living tissues.
23,50,69,70
 
While FLIM has shown considerable flexibility and 
utility in a number of studies in the field of tissue 
engineering, there is still much discussion regarding 
the optimum FLIM analysis methodology.  
One such method, known as Phasor analysis, has 
proven its utility as a fit-free and label-free approach 
to probing cellular environments and identifying 
biologically relevant details regarding cell fate. 
Rather than fitting multiple lifetimes of one or 
multiple species, Phasor analysis represents each 
lifetime as a vector defined by its modulation and 
phase – thereby removing the need for a priori 
knowledge of each species' specific lifetimes.
21
 This 
likewise means that relative concentrations of each 
species can readily be determined by simply 
ascertaining the ratio of their phasor representations. 
This method has recently been employed in 
characterizing the different metabolic and 
differentiation states of both C. Elegans and human 
endothelial stem cells.
21,67 
(see in particular at14  
http://www.nature.com/srep/2013/131205/srep 
03432/full/srep03432.html 
However, for species that are close to each other on 
the phasor diagram, phenomena such as photo-
bleaching and quenching could account for 
significant error in assessing relative species' 
concentrations. Nonetheless, as a non-invasive, non-
destructive, and label-free imaging modality that can 
identify cellular differentiation and metabolic states, 
the phasor approach to FLIM is a promising imaging 
modality for future muscle tissue engineering 
applications.  
Optical Coherence Tomography 
Another potential strategy for the real-time, non-
invasive, and label-free assessment of the structure and 
function of engineered tissue is optical coherence 
tomography (OCT). OCT is an interferometry 
technique that uses broadband near-infrared light at 
wavelengths greater than 800 nm, allowing for deeper 
tissue penetration (approx. 2000 mm) than previously-
mentioned near-infrared imaging modalities.
70-73
 OCT 
has been utilized extensively to monitor cell location, 
migration, differentiation, and interaction with local 
biomaterials.
74-76
 Thanks to its near-cellular level 
resolution, OCT has been employed in investigations 
that would have otherwise been prohibitively 
challenging with other imaging modalities, such as the 
study of structural changes in the retina,
77
 the 3D 
characterization of polylactate and chitosan scaffolds,
78
 
and the kinetics of cell integration into collagen, 
agarose, and other hydrogels.
72,73,75,79,80
 In addition, 
OCT has also been utilized to monitor the optical 
attenuation of cells that were cultured within agarose 
gels.
81
 Other studies have utilized OCT to monitor 
macroscopic tissue regeneration via such processes as 
calcification in gelatin scaffolds and the growth of skin 
models.
75,79,80,82-85
 
In many recent studies, OCT has been combined with 
other imaging or processing techniques to image cells 
and assess their deposition onto engineered tissue 
scaffolds in vitro. Additionally, the combination of 
OCT and Doppler velocimetry has revealed a 
technique that can image micron-level fluid flow, 
allowing for noninvasive and real-time imaging of 
engineered tissue rheological and elastic properties.
75,83
 
Another type of OCT, known as Time Domain OCT, 
has likewise been utilized for the noninvasive imaging 
of the porosity of polymer foam scaffolds that have 
been seeded with aggregates of cells.
86
 In this 
investigation, cell proliferation and extracellular matrix 
deposition could be monitored as a function of the 
allowable imaging depth and the degree to which 
porosity could be detected over time. In another type of 
OCT, whole-field OCT was employed, along with the 
use of magnetic beads as a contrast agent, to observe 
changes in cellular morphology within engineered 
bone tissue in vitro.
86
 Likewise, OCT has been shown 
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to have efficacy in combination with fluorescence 
imaging techniques to optimize cellular or material 
visibility within engineered scaffolds, enabling the 
investigation of how scaffold porosity and structural 
architecture can play a role in governing cell 
morphology.
75,80,87
 The overall adaptability of OCT to 
many different types of investigations, in addition to its 
being noninvasive, non-destructive, and label-free, 
makes it an encouraging imaging modality for use in 
future tissue engineering applications. 
Positron Emission Tomography 
Position Emission Tomography (PET) is an extremely 
valuable clinical diagnostic imaging modality that aims 
to assess physiological function in situ in the human 
body in a non-invasive manner. PET relies on the 
emission of a positron from a radioactive 
pharmaceutical, or radiopharmaceutical, which then 
decays into two coincident photons that can be 
collected and traced by imaging equipment. This 
technique has been especially useful in the diagnosis of 
many types of cancer, and has likewise shown efficacy 
in diagnosing hyperthyroidism and detecting localized 
inflammation through mapping the distributions of 
leukocyte.
88
 While many radiopharmaceuticals may be 
used as Fluorine-
18
 positron emitters (Table 1), the 
most common by far is 
18
F-fluorodeoxyglucose (FDG) 
which, as a functional glucose analogue, may be used 
as a direct metric for cellular glycolysis – even from 
extremely low cell concentrations.
89-91
 
PET imaging in accordance with the use of FDG could 
provide considerably more information when 
measuring the metabolic capacity of engineered tissue 
constructs. However, even the smallest commercially-
available PET scanners, typically used in nuclear 
medicine departments in veterinary facilities, are 
excessively bulky to directly be repurposed for small 
tissue construct imaging. Additionally, average system 
resolutions for these scanners are typically on the order 
of 4.5- 5.0mm and would thereby be ineffectual for 
resolving important details in tissue engineered 
constructs any smaller than this size.
5
 Design proposals 
therefore must include some method of controlling the 
resolution loss attributed to positron blur – the 
governing source blur in PET imaging. 
To ameliorate the reduction of resolution from positron 
blur, simultaneous imaging with PET and magnetic 
resonance imaging (MRI) have been proposed and 
have recently been utilized for small animal studies.
93-
95
 The presence of a unidirectional magnetic field was 
C
A
B
 
 
Fig 3. The potential function of a portable simultaneous PET/MR scanner. A) Theoretical design abstraction of a 
portable simultaneous PER/MR scanner. B) Example output of a small-animal PET/MR scan.
142
 C) Monte Carlo 
simulation comparing the positron pathlengths in traditional PET (blue) and simultaneous PET/MR (red), 
illustrating a greatly-increased resolution in PET/MR. 
Simultaneous imaging with PET and MRI combined modalities may become a powerful monitoring technique for 
the functional assessment of engineered muscle tissue – especially in regards to the characterization of engineered 
muscle glycolosis versus fatty acid metabolism. However, to accurately discern its utility in this regard, further 
research on the miniaturization of these scanners for use on engineered tissue constructs will be necessary. 
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originally theorized in combination with PET 
imaging,
96, 97
 but its effects on image resolution have 
only recently been characterized (Fig. 3).
13
 However, 
recent advances in the electronics involved with such a 
system have made it possible to fabricate a working 
device. In order to construct the proposed device, one 
would have to take into account issues with function 
due to the interferences between the PET imaging 
mechanism and the magnetic field. For instance, PET 
detectors are typically comprised of scintillation 
crystals coupled with photomultiplier tubes. The 
sensitivity of these tubes, along with other electrical 
and radiofrequency components, towards an magnetic 
field would be a major constraint, but recently, silicon 
photomultipliers have been considered for use in 
combination with magnetic fields present from MRI 
imaging.
98-100
 These photomultipliers have been shown 
to be able to resolve most of these issues, as silicon 
based avalanche photodiodes utilize very short optical 
fiber bundles, which are not affected by the presence of 
external electromagnetic field fluxes up to 4.0T. 
Simultaneous imaging with PET and MRI combined 
modalities may become a powerful monitoring 
technique for the functional assessment of engineered 
muscle tissue – especially in regards to the 
characterization of engineered muscle glycolosis 
versus fatty acid metabolism. However, to accurately 
discern its utility in this regard, further research on the 
miniaturization of these scanners for use on engineered 
tissue constructs will be necessary 
Bioluminescent Imaging 
Bioluminescent Imaging (BLI) is an imaging technique 
that relies on emitted light from the enzymatic 
generation of luminescence in living organisms. BLI 
typically requires the introduction of the luciferase 
gene from Photinus pyralis into a receptive cell line or 
tissue. The luciferase and luciferin reaction results in 
the emission of photons from 500-620 nm (blue-green 
to yellow-orange) wavelengths, with peak emission at 
612 nm at 37C.
101,102
 However, luciferase from the 
Renilla wildtype emits light from 460-490 nm.
103,104
 
Additionally, small genetic changes in these luciferase 
reporters' encoding DNA can be made to adjust their 
emission wavelengths without significant changes to 
the biochemical reaction – thereby allowing for the 
potential to utilize multiple luciferase reporters in the 
same engineered tissue to simultaneously investigate 
multiple biological processes.
45
 Aside from 
transfection, luciferase may be introduced to tissue via 
simple diffusion – a technique employed by many 
investigations to characterize perfusion in vascularized 
tissue constructs or live animal models.
101,105
 
Many studies utilize BLI to track cells following 
implantation, providing detailed information on cell 
viability, migration, differentiation, and integration 
with surrounding scaffolds and/or tissues.
88,106,107
 
Additionally, stem cell viability, migration, and 
proliferation have been monitored for months using 
BLI on various engineered polymer scaffolds in both 
bioreactor and non-bioreactor culture conditions.
108-110
 
The potential for lengthy investigations has given rise 
to many current projects aiming to monitor temporal 
changes in not only cytotoxicity, but also cell gene 
expression, the progression of infection, and the 
growth and angiogenesis of tumors.
111
 Investigations 
on the formation of bone in mice in vivo have likewise 
relied on luciferase transfection to gauge the degree to 
which bone formation from extant bone and introduced 
stem cell sources occurred.
88,106, 112-114
 BLI has recently 
become a modality of great interest from within the 
tissue engineering community – primarily for its 
noninvasive, non-destructive, and longitudinal imaging 
of cells and engineered tissue, both in vivo and in vitro. 
However, transfection of a luciferase reporter gene is 
invasive and potentially destructive to target cells and 
tissues, and spatial information is limited to two 
dimensions. Current BLI research calls for the 
development of optimum luciferase transfection or 
introduction strategies, along with an imaging system 
that allows for simultaneous 3D spatial acquisition. 
Micro X-ray Computed Tomography 
Micro X-ray Computer Tomography (μCT) is another 
promising imaging modality for the functional 
assessment of engineered tissue, as it allows for the 
non-destructive quantification of many aspects of 
engineered scaffolds, such as porosity, pore size, and 
interconnectivity.
115-122
 Inferring cellular integration 
and interaction with its engineered scaffold is made 
possible in μCT, as images can be acquired 
sequentially over time with minimal negative affects to 
cells from X-ray dose.
123,124
 However, in order to 
achieve suffiecient X-ray absorption (contrast), soft 
tissues and biomaterials oftentimes need to be freeze-
dried or kept under dry conditions instead of standard 
culture conditions – a notion which can significantly 
affect certain cell or tissue types. Due to this X-ray 
absorption issue, μCT is most commonly associated 
with the characterization of engineered bone tissue, as 
the comparatively high X-ray absorption of calcium 
eliminates the need for freeze-drying in mineralized 
tissues and hydrogels (Fig. 4).
125,126
 In these types of 
studies, μCT can allow the for noninvasive, non-
destructive, and label-free assessment of mineralization 
as a function of time with minimal affect to the tissue 
or engineered construct being imaged.
127,128
. 
In studies involving on-mineralized tissue, many 
techniques have otherwise been imployed to minimize 
the aforementioned negative affects of conventional 
μCT use. For example, contrast agents such as heavy 
metal, barium sulfate, or Microfil may be used to 
image anything from 3D scaffold architectures to blood 
vessel or neural tissue integration and 
neovascularization within engineered tissues.
129-134
 
High resolution μCT has also been utilized in vivo to 
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identify stem cells that were labeled with magnetic 
nanoparticles following an intra-arterial 
transplant.
135http://www.ncbi.nlm.nih.gov/pmc/article
s/PMC3799904/ - R180 However, the use of contrast 
agents, dyes, or radioactive labels always results in the 
destruction of engineered tissue, so functional 
assessment of engineered constructs or post-transplant 
engineered tissues is limited to longitudinal studies 
assessing multiple timepoints from individual subjects 
or constructs. 
Conclusions 
The impact that the aforementioned imaging modalities 
have on muscle tissue engineering is constantly 
growing. The impressive advances of electron 
microscopy 3D reconstruction of molecular and 
supramolecular fine details of muscle fibers are well 
exemplified in the first issue of the EJTM Special 
mini-series “News on Muscle imaging”.145-150  
Further, there are pressing needs for the noninvasive, 
non-destructive, real-time methods for the functional 
assessment of cells and tissues. As it currently stands, 
imaging modalities such as PAM, FLIM, and BLI 
seem optimally suited for in vitro application due to 
their depth of resolution limitations, whereas μCT, 
OCT, TPEF, and PET are making great strides towards 
being relevant in large-muscle construct or in vivo 
work. However, promising new analysis methods 
and/or combinations of these modalities offer exciting 
glimpses at their future applicability to a wide range of 
myology studies.  
In order to translate the basic experimental results of 
muscle tissue engineering and regenerative myology 
into the clinical setting, it is critical that researchers 
identify and exploit the strengths of each of these 
imaging modalities. Further optimization of these 
systems will be pivotal in discerning their respective 
utility in serving the complex and challenging field of 
tissue engineering. To progress and replace extant 
methods for functional tissue assessment, the modern 
imaging systems will need to be highly accurate, 
reliable, inexpensive, fast and automated. Ideally, these 
systems must be flexible in applications with 
traditional in vitro protocols, emerging bioreactor 
systems and current in vivo studies. 
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